Effects of insulin therapy on inflammatory mediators in infants undergoing cardiac surgery with cardiopulmonary bypass

Cytokine

Volumn 44, Issue 1, 2008, Pages 96-100

  Gu, Chun Hu ^a   Cui, Qin ^a   Wang, Yun Ya ^a   Wang, Jing ^a   Dou, Ya Wei ^a   Zhao, Rong ^a   Liu, Yang ^a   Wang, Jin ^a   Pei, Jian Ming ^b   Yi, Ding Hua ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cardiopulmonary bypass; I B; Insulin; Interleukin; Nuclear factor Bp65; Tumor necrosis factor

Indexed keywords

I KAPPA B; INSULIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANESTHESIA; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART SURGERY; HUMAN; INFANT; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; WESTERN BLOTTING;

BLOOD GLUCOSE; CARDIOPULMONARY BYPASS; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; I-KAPPA B PROTEINS; INFANT; INFLAMMATION; INFLAMMATION MEDIATORS; INSULIN; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTRAOPERATIVE PERIOD; MALE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 52949106830     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.06.014     Document Type: Article

References (25)

1. Aebert H., Kirchner S., Keyser A., Birnbaum D.E., Holler E., Andreesen R., et al. Endothelial apoptosis is induced by serum of patients after cardiopulmonary bypass. Eur J Cardiothorac Surg 18 (2000) 589-593
2. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85 (1999) 221-228
3. Wang H., Bloom O., Zhna M., Vishnubhakat J.M., Ombrellino M., Che J., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285 (1999) 248-251
4. Tracey K.J., Fong Y., Hesse D.G., Manogue K.R., Lee A.T., Kuo G.C., et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330 (1987) 662-664
5. Jeschke M.G., Klein D., Bolder U., and Einspanier R. Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology 145 9 (2004) 4084-4093
6. Dandona P., Aljada A., Mohanty P., Ghanim H., Hamouda W., Assian E., et al. Insulin inhibits intranuclear nuclear factor κB and stimulates IκB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?. J Clin Endocrinol Metab 86 (2001) 3257-3265
7. Baeuerle P.A., and Henkel T. Function and activation of NF-κ B in the immune system. Annu Rev Immunol 12 (1994) 141-179
8. Van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., et al. Intensive insulin therapy in critically ill patients. N Engl J Med 345 (2001) 1359-1367
9. Van den Berghe G., Wilmer A., Hermans G., Meersseman W., Wouters P.J., Milants I., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 354 5 (2006) 449-461
10. Jeschke M.G., Einspanier R., Klein D., and Jauch K.W. Insulin attenuates the systemic inflammatory response to thermal trauma. Mol Med 8 (2002) 443-450
11. Jeschke M.G., Klein D., and Herndon D.N. Insulin treatment improves the systemic inflammatory reaction and hepatic acute-phase-response to severe thermal injury. Ann Surg 239 (2004) 553-560
12. Aljada A., Ghanim H., Mohanty P., Kapur N., and Dandona P. Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. J Clin Endocrinol Metab 87 (2002) 1419-1422
13. Furnary A.P., and Wu Y. Clinical effects of hyperglycemia in the cardiac surgery population: the Portland diabetic project. Endocr Pract 12 Suppl. 3 (2006) 22-26
14. Liu Y.-L., Bi H., Chi S.-M., Fan R., Wang Y.-M., Ma X.-L., et al. The effect of compound nutrients on the stress-induced serum IL-2, IL-6 and TNF-α levels in rat. Cytokine 37 (2007) 14-21
15. Golden S.H., Peart-Vigilance C., Kao W.H., and Brancati F.L. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care 22 9 (1999) 1408-1414
16. Watarida S., Mori A., Onoe M., Tabata R., Shiraishi S., Sugita T., et al. A clinical study on the effects of pulsatile cardiopulmonary bypass on the blood endotoxin levels. J Thorac Cardiovasc Surg 108 (1994) 620-625
17. Ha H., Yu M.R., Choi Y.J., Kitamura M., and Lee H.B. Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells. Am Soc Nephrol 13 (2002) 894-902
18. Beutler B., Milsark J.M., and Cerami A. Cachectin/tumor necrosis factor production distribution, and metabolic fate in vivo. J Immunol 135 (1985) 3972-3977
19. VanDamme J. In: Thomson A. (Ed). Interleukin-8 and related molecules (1991), Academic Press Ltd., London 201-214
20. Emanuelli B., Peraldi P., Filloux C., Sawka-Verhelle D., Hilton D., and Van Obberghen E. SOCS-3 is an insulin-induced negative regulator of insulin signalling. J Biol Chem 275 (2000) 15985-15991
21. Nelson P.J., Kim H.T., Manning W.C., Goralski T.J., and Krensky A.M. Genomic organization and transcriptional regulation of the RANTES chemokine gene. J Immunol 151 (1993) 2601-2612
22. Pruitt J.H., Copeland E.M., and Moldawer L.L. Interleukin-1 and interleukin-1 antagonism in sepsis systemic inflammatory response syndrome and septic shock. Shock 3 (1999) 235-251
23. Alexander H.R., Doherty G.M., and Buresh C.M. A recombinant human receptor antagonist to interleukin-1 improves survival after lethal endotoxemia in mice. J Exp Med 173 (1991) 1029-1032
24. Tripathy D., Mohanty P., Dhindsa S., Syed T., Ghanim H., Aljada A., et al. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes 52 (2003) 2882-2887
25. Dandona P., Aljada A., and Mohanty P. The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia 45 (2002) 924-930